podcast.de
Anmeldung
Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 15/22 Podcast
  4. Meaning in life in the federal Republic of Germany: results of a representative survey with the Schedule for Meaning in Life Evaluation (SMiLE)
Background: The construct "meaning- in- life" (MiL) has recently
raised the interest of clinicians working in psycho-oncology and
end-of-life care and has become a topic of scientific
investigation. Difficulties regarding the measurement of MiL are
related to the various theoretical and conceptual approaches and
its inter- individual variability. Therefore the "Schedule for
Meaning in Life Evaluation" (SMiLE), an individualized instrument
for the assessment of MiL, was developed. The aim of this study was
to evaluate MiL in a representative sample of the German
population. Methods: In the SMiLE, the respondents first indicate a
minimum of three and maximum of seven areas which provide meaning
to their life before rating their current level of importance and
satisfaction of each area. Indices of total weighting (loW, range
20-100), total satisfaction (loS, range 0-100), and total weighted
satisfaction (loWS, range 0-100) are calculated. Results: In July
2005, 1,004 Germans were randomly selected and interviewed
(inclusion rate, 85.3%). 3,521 areas of MiL were listed and
assigned to 13 a- posteriori categories. The mean loS was 81.9 +/-
15.1, the mean loW was 84.6 +/- 11.9, and the mean loWS was 82.9
+/- 14.8. In youth (16-19 y/o), "friends" were most important for
MiL, in young adulthood (20-29 y/o) "partnership"

Weitere Episoden

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

vor 17 Jahren
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

vor 17 Jahren
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

vor 17 Jahren
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

vor 17 Jahren
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

vor 17 Jahren
Alle Episoden anzeigen
In Podcasts werben
Schalte jetzt Werbung in Podcasts.
Episode melden

„Meaning in life in the federal Republic of Germany: results of a representative survey with the Schedule for Meaning in Life Evaluation (SMiLE)“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz